{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04859296",
            "orgStudyIdInfo": {
                "id": "21-000208"
            },
            "organization": {
                "fullName": "University of California, Los Angeles",
                "class": "OTHER"
            },
            "briefTitle": "AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)",
            "officialTitle": "Analgesic and Appetite-stimulating Effects of Cannabigerol Administered Alone and in Combination With Delta-9-tetrahydrocannabinol",
            "acronym": "ASCENT",
            "therapeuticArea": [
                "Other"
            ],
            "study": "analgesic-and-appetite-stimulating-effects-of-cannabigerol-and-thc-ascent"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-02-15",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-06-22",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-06-22",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-04-21",
            "studyFirstSubmitQcDate": "2021-04-21",
            "studyFirstPostDateStruct": {
                "date": "2021-04-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-25",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Ziva D. Cooper, PhD",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "University of California, Los Angeles"
            },
            "leadSponsor": {
                "name": "University of California, Los Angeles",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Center for Medicinal Cannabis Research",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study will assess the analgesic, appetite-stimulating, and subjective effects of cannabigerol (CBG) alone and in combination with THC.",
            "detailedDescription": "The overall aim of this double-blind, placebo-controlled, within-subject study in healthy, occasional cannabis smokers is to ascertain the dose-dependent analgesic and appetite-stimulating effects of ecologically relevant doses of cannabigerol (CBG) alone and in combination with a sub-analgesic / sub-appetite stimulating, minimally psychoactive dose of THC and an analgesic, appetite-stimulating, but intoxicating dose of THC."
        },
        "conditionsModule": {
            "conditions": [
                "Pain",
                "Appetite Loss",
                "Abuse, Drug"
            ],
            "keywords": [
                "Analgesia",
                "Pain",
                "Appetite",
                "THC",
                "Cannabigerol",
                "CBG"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "interventionModelDescription": "This is a randomized, double-blind, placebo-controlled study. All participants will complete all dose conditions in a randomized order.",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "DOUBLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "0 mg CBG, 0 mg THC",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Low strength CBG",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "5 mg CBG, 0 mg THC",
                    "interventionNames": [
                        "Drug: Low CBG"
                    ]
                },
                {
                    "label": "High strength CBG",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "15 mg CBG, 0 mg THC",
                    "interventionNames": [
                        "Drug: High CBG"
                    ]
                },
                {
                    "label": "Low strength THC",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "0 mg CBG, 5 mg THC",
                    "interventionNames": [
                        "Drug: Low THC"
                    ]
                },
                {
                    "label": "High strength THC",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "0 mg CBG, 30 mg THC",
                    "interventionNames": [
                        "Drug: High THC"
                    ]
                },
                {
                    "label": "Low strength CBG + Low strength THC",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "5 mg CBG + 5 mg THC",
                    "interventionNames": [
                        "Drug: Low CBG",
                        "Drug: Low THC"
                    ]
                },
                {
                    "label": "Low strength CBG + High strength THC",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "5 mg CBG + 15 mg THC",
                    "interventionNames": [
                        "Drug: Low CBG",
                        "Drug: High THC"
                    ]
                },
                {
                    "label": "High strength CBG + Low strength THC",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "15 mg CBG + 5 mg THC",
                    "interventionNames": [
                        "Drug: High CBG",
                        "Drug: Low THC"
                    ]
                },
                {
                    "label": "High strength CBG + High strength THC",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "15 mg CBG + 15 mg THC",
                    "interventionNames": [
                        "Drug: High CBG",
                        "Drug: High THC"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Vaporized placebo",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Low CBG",
                    "description": "Vaporized CBG (5 mg)",
                    "armGroupLabels": [
                        "Low strength CBG",
                        "Low strength CBG + High strength THC",
                        "Low strength CBG + Low strength THC"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "High CBG",
                    "description": "Vaporized CBG (15 mg)",
                    "armGroupLabels": [
                        "High strength CBG",
                        "High strength CBG + High strength THC",
                        "High strength CBG + Low strength THC"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Low THC",
                    "description": "Vaporized THC (5 mg)",
                    "armGroupLabels": [
                        "High strength CBG + Low strength THC",
                        "Low strength CBG + Low strength THC",
                        "Low strength THC"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "High THC",
                    "description": "Vaporized THC (15 mg)",
                    "armGroupLabels": [
                        "High strength CBG + High strength THC",
                        "High strength THC",
                        "Low strength CBG + High strength THC"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Analgesia",
                    "description": "Pain threshold and pain tolerance assessed with the Cold Pressor Test - time to report first feeling pain (0-180 seconds) and remove the hand from the cold water (0-180 seconds). Increased duration means increased pain tolerance and pain threshold.",
                    "timeFrame": "7 hours"
                },
                {
                    "measure": "Appetite stimulation",
                    "description": "Subjective ratings of hunger assessed with a visual analog scale (0-100 mm; 0 mm = no effect, 100 mm = maximum possible effect). Higher ratings indicate higher ratings of hunger / appetite stimulation.",
                    "timeFrame": "7 hours"
                },
                {
                    "measure": "Abuse liability",
                    "description": "Subject ratings of \"Good Drug Effect\" as measured using a visual analog scale (0-100 mm; 0 mm = no effect, 100 mm = maximum possible effect). Higher ratings indicate higher ratings of abuse liability.",
                    "timeFrame": "7 hours"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Subjective ratings of intoxication",
                    "description": "Subject ratings of \"High\" as measured using a visual analog scale (0-100 mm; 0 mm = no effect, 100 mm = maximum possible effect). Higher ratings indicate higher ratings of intoxication.",
                    "timeFrame": "7 hours"
                },
                {
                    "measure": "Subjective ratings of pain",
                    "description": "Subject ratings of Painfulness and Bothersomeness of the Cold Pressor Test. Scale is from 0 (Not painful / bothersome at all) to 10 (The most painful / bothersome feeling imaginable), higher ratings indicate greater painfulness and bothersomeness.",
                    "timeFrame": "7 hours"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or non-pregnant and non-lactating females aged 21-55 years\n* \u2022 Report occasional use of cannabis (cannabis use between \u2265 biweekly and \u2264 3 days per week) over the month prior to screening\n* Not currently seeking treatment for their cannabis use\n* Have a Body Mass Index from 18.5 - 34kg/m2.\n* Able to perform all study procedures\n* Must be using a contraceptive (hormonal or barrier methods)\n* Females must not be lactating\n\nExclusion Criteria:\n\n* Meeting DSM-V criteria for moderate-severe Cannabis Use disorder (CUD) or any substance use disorder other than nicotine, caffeine, or mild CUD\n* Any other Axis I disorder\n* \u2022 Current use of any medications within 14 days or 5 half-lives of administration (whichever is longer) except for hormonal contraceptives in females. If a medication is taken once a participant is enrolled, sessions will be suspended for 14 days or 5 half-lives after administration (whichever is longer)\n* If medical history, physical and psychiatric examination, or laboratory tests performed during the screening process are not within the normal range and / or reveal any significant illness (e.g., hypertension) as judged by the study physician and to put the participant at greater risk of experiencing adverse events due to completion of study procedures.\n* Current pain\n* Pregnancy is exclusionary due to the possible effects of the study medication on fetal development.\n* History of an allergic reaction or adverse reaction to cannabis is exclusionary.\n* History of respiratory illness or current respiratory illness\n* Currently enrolled in another research protocol\n* Not using a contraceptive method (hormonal or barrier methods)\n* Insensitivity to the cold water stimulus of the Cold Pressor Test\n* Any disorders that might make cannabis administration hazardous are exclusionary, as determined by the evaluating physician",
            "healthyVolunteers": true,
            "sex": "ALL",
            "genderBased": true,
            "genderDescription": "Prospective research participants will be healthy, occasional (cannabis use biweekly to \u2264 3 day per week) cannabis-using men and non-pregnant and non-lactating women who will be evaluated for participation according to the following inclusion/exclusion criteria.",
            "minimumAge": "21 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Ziva D Cooper, PhD",
                    "role": "CONTACT",
                    "phone": "310-206-9942",
                    "email": "zcooper@mednet.ucla.edu"
                },
                {
                    "name": "Vincent Acebo",
                    "role": "CONTACT",
                    "phone": "310-983-3417",
                    "email": "vacebo@mednet.ucla.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Ziva D Cooper, PhD",
                    "affiliation": "University of California, Los Angeles",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of California, Los Angeles",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ziva D Cooper, PhD",
                            "role": "CONTACT",
                            "phone": "310-794-7497",
                            "email": "zcooper@mednet.ucla.edu"
                        },
                        {
                            "name": "Vincent Acebo",
                            "role": "CONTACT",
                            "phone": "310-983-3417",
                            "email": "vacebo@mednet.ucla.edu"
                        },
                        {
                            "name": "Ziva D Cooper, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4181",
                    "name": "Anorexia",
                    "relevance": "LOW"
                },
                {
                    "id": "M13066",
                    "name": "Pain",
                    "relevance": "LOW"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "asFound": "Abuse, Drug",
                    "relevance": "HIGH"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013759",
                    "term": "Dronabinol"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006213",
                    "term": "Hallucinogens"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000011619",
                    "term": "Psychotropic Drugs"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000063386",
                    "term": "Cannabinoid Receptor Agonists"
                },
                {
                    "id": "D000063385",
                    "term": "Cannabinoid Receptor Modulators"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16527",
                    "name": "Dronabinol",
                    "asFound": "1500",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M9305",
                    "name": "Hallucinogens",
                    "relevance": "LOW"
                },
                {
                    "id": "M14474",
                    "name": "Psychotropic Drugs",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}